Bhurichaya Innets

Bangkok, Thailand

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Polysaccharides Derived from Caulerpa lentillifera (Sea Grape) Inhibit Melanogenesis in Human Melanoma Cells and Promote Stemness in Stem Cells.

Polysaccharides Derived from Caulerpa lentillifera (Sea Grape) Inhibit Melanogenesis in Human Melanoma Cells and Promote Stemness in Stem Cells.

Journal: In vivo (Athens, Greece)
Published: May 29, 2025

Resveratrol Derivatives Inhibit Pro-survival Akt Signaling Pathway in Lung Cancer.

Resveratrol Derivatives Inhibit Pro-survival Akt Signaling Pathway in Lung Cancer.

Journal: Anticancer research
Published: May 06, 2025

Development of a Benzoxazine-derived Inhibitor Targeting Epithelial-to-Mesenchymal Transition in Lung Cancer.

Development of a Benzoxazine-derived Inhibitor Targeting Epithelial-to-Mesenchymal Transition in Lung Cancer.

Journal: Anticancer research
Published: March 17, 2025

A Randomized Double-Blind Controlled Evaluation of the Therapeutic Benefits of an Herbal Lip Hydrant.

A Randomized Double-Blind Controlled Evaluation of the Therapeutic Benefits of an Herbal Lip Hydrant.

Journal: Journal of cosmetic dermatology
Published: October 12, 2024

Correction: Thepthanee et al. Shrimp Lipids Inhibit Migration, Epithelial-Mesenchymal Transition, and Cancer Stem Cells via Akt/mTOR/c-Myc Pathway Suppression. Biomedicines 2024, 12, 722.

Correction: Thepthanee et al. Shrimp Lipids Inhibit Migration, Epithelial-Mesenchymal Transition, and Cancer Stem Cells via Akt/mTOR/c-Myc Pathway Suppression. Biomedicines 2024, 12, 722.

Journal: Biomedicines
Published: June 24, 2024

Shrimp Lipids Inhibit Migration, Epithelial-Mesenchymal Transition, and Cancer Stem Cells via Akt/mTOR/c-Myc Pathway Suppression.

Shrimp Lipids Inhibit Migration, Epithelial-Mesenchymal Transition, and Cancer Stem Cells via Akt/mTOR/c-Myc Pathway Suppression.

Journal: Biomedicines
Published: February 09, 2024

Light-Mediated Transformation of Renieramycins and Semisynthesis of 4'-Pyridinecarbonyl-Substituted Renieramycin-Type Derivatives as Potential Cytotoxic Agents against Non-Small-Cell Lung Cancer Cells.

Light-Mediated Transformation of Renieramycins and Semisynthesis of 4'-Pyridinecarbonyl-Substituted Renieramycin-Type Derivatives as Potential Cytotoxic Agents against Non-Small-Cell Lung Cancer Cells.

Journal: Marine drugs
Published: June 24, 2023

Semisynthesis of 5-O-ester derivatives of renieramycin T and their cytotoxicity against non-small-cell lung cancer cell lines.

Semisynthesis of 5-O-ester derivatives of renieramycin T and their cytotoxicity against non-small-cell lung cancer cell lines.

Journal: Scientific reports
Published: March 19, 2023

Novel Synthetic Derivative of Renieramycin T Right-Half Analog Induces Apoptosis and Inhibits Cancer Stem Cells via Targeting the Akt Signal in Lung Cancer Cells.

Novel Synthetic Derivative of Renieramycin T Right-Half Analog Induces Apoptosis and Inhibits Cancer Stem Cells via Targeting the Akt Signal in Lung Cancer Cells.

Journal: International journal of molecular sciences
Published: February 01, 2023

Akt/mTOR Targeting Activity of Resveratrol Derivatives in Non-Small Lung Cancer.

Akt/mTOR Targeting Activity of Resveratrol Derivatives in Non-Small Lung Cancer.

Journal: Molecules (Basel, Switzerland)
Published: October 04, 2022
Showing 1-10 of 10

Last Updated: 09/26/2026